MedTrace Logo

Survival of the Insignia Stem in Total Hip Arthroplasty

NCT05313321 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-01-09

No results posted yet for this study

Summary

The investigators primary objective of this study is to evaluate radiographic fit and fill of the Insignia stem and identify risk factors for aseptic failure. The investigators hypotheses being tested is: the newly designed Insignia stem demonstrates acceptable radiographic fit and fill by reviewing radiolucent lines \<2mm.

Conditions

  • Primary Total Hip Arthroplasty

Interventions

DEVICE

Primary total hip arthroplasty receiving the Insignia Stem

Patients receiving the Insignia Stem and associated Stryker Acetabular Component for total hip arthroplasty

Sponsors & Collaborators

Principal Investigators

  • Lucas Anderson, M.D. · University of Utah Orthopaedics

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-17
Primary Completion
2028-03-31
Completion
2028-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05313321 on ClinicalTrials.gov